Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2012
09/05/2012CN101926983B Artificial nano red blood cells
09/05/2012CN101919879B Method for preparing probiotics preparation by taking attapulgite as carrier
09/05/2012CN101906140B Aliphatic chain and YIGSR pentapeptide conjugate, and synthesizing method and application thereof
09/05/2012CN101899091B Fatty alkyl pentapeptide conjugate, preparation method thereof and application thereof in medical science
09/05/2012CN101897673B Method for preparing vitamin C tablet
09/05/2012CN101891803B New cartilaginous affinity polypeptide sequence, screening method and application thereof
09/05/2012CN101891801B Saturated aliphatic chain alcohol RGD (Arginyl-Glycyl-Aspartic acid) pentapeptide diester compound, synthesis method and application thereof
09/05/2012CN101874805B Compound dexamethasone acetate gel and preparation method thereof
09/05/2012CN101862233B Drug-delivery endovascular stent and method for treating restenosis
09/05/2012CN101857615B Leucosceptoside B and preparation method and application thereof
09/05/2012CN101842079B Non-aqueous pharmaceutical compositions
09/05/2012CN101831468B Synthesis of medicinal biodegradable poly(epsilon-caprolactone) and application method thereof
09/05/2012CN101804030B Sodium dichlorophenolate micro-pill pharmaceutical preparation and preparation method thereof
09/05/2012CN101797239B Strychnos alkaloid vesicle and preparation method thereof
09/05/2012CN101775399B Asia1 type multi-epitope recombinant vaccine of bovine foot-and-mouth disease viruses and preparation method thereof
09/05/2012CN101773479B Method for preparing shell-core double-layer microspheres
09/05/2012CN101773478B Pulmonary targeting microsphere of veterinary ceftiofur hydrochloride and preparation method thereof
09/05/2012CN101756955B Chinonin complex, preparation method and application thereof
09/05/2012CN101756909B Lung-targeting ceftiofur microsphere and preparation method thereof
09/05/2012CN101735613B Porous polymer nanoparticle and preparation method thereof
09/05/2012CN101721707B Preparation method of pH response drug release carrier on basis of coordinate bond
09/05/2012CN101721373B Solid cefdinir sub-microemulsion and application thereof
09/05/2012CN101708177B Medicine composition containing docetaxel and preparation method thereof
09/05/2012CN101690822B Medicament carrier for targeted medicament delivery on diseases related to macrophage and preparation method thereof
09/05/2012CN101671397B Anti-EGFR single-chain antibody fusion Gelonin recombination immunotoxin, preparation method and usage thereof
09/05/2012CN101669913B Levocetirizine dihydrochloride granule and preparation and detection methods thereof
09/05/2012CN101632742B Chinese medicinal granules for treating breast diseases and preparation method thereof
09/05/2012CN101590108B Method for changing viscosity of Magnolia extract
09/05/2012CN101513439B Notoginseng sodium hyaluronate gel for preventing from adhesion after spine laminectomy
09/05/2012CN101468024B Hormone emulsifiable paste
09/05/2012CN101433537B External-use spray for resisting mycotic infection of superficial part and preparation method thereof
09/05/2012CN101396553B Recombined human blood vessel endothelial inhibin sustained-release injection composition
09/05/2012CN101389356B Drug delivery material
09/05/2012CN101374503B Quickly disintegrating tablet produced by direct dry-tabletting
09/05/2012CN101360486B Nanoparticles for protein drug delivery
09/05/2012CN101336902B Liposomes sodium morrhuate
09/05/2012CN101330931B Production of conjugates
09/05/2012CN101322711B Health care medicament for resisting fatigue and enhancing immunity and preparation thereof
09/05/2012CN101284003B Medicinal composition containing andrographolide derivatives and preparation method thereof and application
09/05/2012CN101240032B Broad spectrum influenza virus resistant antagonistic peptide nasal spray preparation and application
09/05/2012CN101199523B Medicament composition containing levorotatory ammonia chlorine horizon and atorvastatin and preparing method thereof
09/05/2012CN101193916B Anti-integrin immunoconjugates, methods and uses
09/05/2012CN101185653B Breviscapine oral administration composition and preparation method thereof
09/05/2012CN101125207B Exendin or its analogs with polyethylene group and its preparation and application
09/05/2012CN101014323B Phospholipid gel compositions for drug delivery and methods of treating conditions using same
09/05/2012CN101002945B Novel complex used for treating tumor
09/04/2012US8258324 Intermediates useful in the preparation of maleimide functionalized polymers
09/04/2012US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
09/04/2012US8258262 N-terminally chemically modified protein compositions and methods
09/04/2012US8258255 Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
09/04/2012US8258191 Topical skin barriers and methods of evaluation thereof
09/04/2012US8258190 Encapsulated contrast agents
09/04/2012US8258189 Compounds prepared by adding an oxetane derivative to an alcohol
09/04/2012US8258184 Use of vegetable butter-based cetyl myristoleate for treating osteoarthritis and other musculoskeletal disease conditions and injuries
09/04/2012US8258132 Pharmaceutical composition of a tachykinin receptor antagonist
09/04/2012US8258106 Immunostimulatory nucleic acid molecules
09/04/2012US8257745 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
09/04/2012US8257741 Solid pharmaceutical dispersions with enhanced bioavailability
09/04/2012US8257735 Method of increasing the bioavailability of recombinant human insulin isophane in a patient
09/04/2012US8257734 PQS and its conjugates as adjuvants and their uses in pharmaceutical compositions
09/04/2012US8257709 Antibodies against Clostridium difficile toxins and uses thereof
09/04/2012US8257708 Antibodies against cancer antigen TMEFF2 and uses thereof
09/04/2012US8257683 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
09/04/2012CA2737025C Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
09/04/2012CA2555339C Pharmaceutical formulations comprising paraoxonase
09/04/2012CA2541009C Monodispersed solid lipid particle compositions
09/04/2012CA2528411C Method for improving stability and shelf-life of liposome complexes
09/04/2012CA2513276C Compositions containing coenzyme q10
09/04/2012CA2432971C Polypeptides
08/2012
08/30/2012WO2012116357A2 Use of agr3 for treating cancer
08/30/2012WO2012116250A1 Monomers and polymers for functional polycarbonates and poly (ester-carbonates) and peg-co-polycarbonate hydrogels
08/30/2012WO2012116210A2 Peptide for the induction of immune tolerance as treatment for systemic lupus erythematosus
08/30/2012WO2012116177A2 Materials for modulating biological responses and methods of making
08/30/2012WO2012115904A2 Production of n- and o-sialylated tnfrii-fc fusion protein in yeast
08/30/2012WO2012115659A1 Compositions and methods for controlled delivery of compounds
08/30/2012WO2012115655A1 Formulations of canfosfamide and their preparation
08/30/2012WO2012115538A1 Clathrate complex of cyclodextrin or arabinogalactan with 9-phenyl-sym-octahydroselenoxanthene
08/30/2012WO2012115207A1 Biologically active nonaqueous composition for microneedle devices, and biologically active nonaqueous composition adhering to microneedle
08/30/2012WO2012114054A1 Locally acting pharmaceutical compositions which can be administered by cutaneous application
08/30/2012WO2012114051A1 Cutaneous pharmaceutical compositions for the local treatment of canine atopic dermatitis
08/30/2012WO2012113907A2 Paper support and method of recovering biological material therefrom
08/30/2012WO2012113847A1 Branched linker for protein drug conjugates
08/30/2012WO2012113846A1 A system for cargo delivery into the cells
08/30/2012WO2012113803A1 A cyclic peptide and conjugate thereof for binding to keratinocytes
08/30/2012WO2012113733A1 Nanoparticles as mrt contrast media for the diagnosis of hepatocellular carcinoma
08/30/2012WO2012113571A1 Bisphosphonate-prodrugs
08/30/2012WO2012113564A1 Stabilized granules containing glyceryl trinitrate
08/30/2012WO2012113563A1 Packaging of solid pharmaceutical preparations containing the active substance glyceryl trinitrate
08/30/2012WO2012113513A1 Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
08/30/2012WO2012113413A1 Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
08/30/2012WO2012113179A1 Sustained release pharmaceutical composition of zaltoprofen and preparation method thereof
08/30/2012WO2012113117A1 Oral preparation comprising protein or polypeptide, preparation method thereof, and use thereof
08/30/2012WO2012113116A1 Emulsion containing hydrophilic biological macromolecule, preparation method and application thereof
08/30/2012WO2012092990A3 Medical product for improving the ability of a mammal to conceive
08/30/2012WO2012088608A8 Compositions comprising natriuretic peptides and methods of use thereof
08/30/2012WO2012082483A3 Multifunctional linkers and methods for the use thereof
08/30/2012WO2012080184A3 Liquid pharmaceutical compositions which can be administered orally and contain 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophene carboxamide
08/30/2012WO2012068476A3 Poly(vinyl benzoate) nanoparticles for molecular delivery
08/30/2012WO2012062904A3 Compositions and methods for the prevention and treatment of cancer
08/30/2012WO2012057492A3 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein a-i and a mutant thereof
1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 1712